Showing 1 - 6 results of 6 for search 'Yejing Zhu', query time: 0.04s
Refine Results
-
1
-
2
Computational Characterizing Necroptosis Reveals Implications for Immune Infiltration and Immunotherapy of Hepatocellular Carcinoma by Jun Zhu, Jun Zhu, Tenghui Han, Shoujie Zhao, Yejing Zhu, Shouzheng Ma, Fenghua Xu, Tingting Bai, Yuxin Tang, Yungang Xu, Yungang Xu, Lei Liu
Published 2022-07-01
Article -
3
Implications of Laboratory Tests in Disease Grading and Death Risk Stratification of COVID-19: A Retrospective Study in Wuhan, China by Yang Bai, Yang Bai, Enxin Wang, Shoujie Zhao, Jing Li, Yejing Zhu, Yongchao Zhang, Liang Cao, Haitao Liu, Yushu Dong, Fang Wang, Fang Wang, Guobiao Liang, Lei Liu
Published 2021-02-01
Article -
4
Insights into the Effect of Catalytic Intratumoral Lactate Depletion on Metabolic Reprogramming and Immune Activation for Antitumoral Activity by Junlong Zhao, Zhimin Tian, Shoujie Zhao, Dayun Feng, Zhixiong Guo, Liangzhi Wen, Yejing Zhu, Fenghua Xu, Jun Zhu, Shouzheng Ma, Jie Hu, Tao Jiang, Yongquan Qu, Dongfeng Chen, Lei Liu
Published 2023-02-01
Article -
5
Potential candidates for liver resection in liver-confined advanced HCC: a Chinese multicenter observational study by Tingting Bai, Enxin Wang, Shoujie Zhao, Dandan Han, Yan Zhao, Hui Chen, Jun Zhu, Tenghui Han, Yang Bai, Yanju Lou, Yongchao Zhang, Man Yang, Luo Zuo, Jiahao Fan, Xing Chen, Jia Jia, Wenbin Wu, Weirong Ren, Yejing Zhu, Shouzheng Ma, Fenghua Xu, Yuxin Tang, Xilin Du, Junlong Zhao, Jing Li, Jing Li, Xingshun Qi, Ying Han, Dongfeng Chen, Lei Liu, Lei Liu
Published 2023-06-01
Article -
6
Identify optimal HAP series scores for unresectable HCC patients undergoing TACE plus sorafenib: A Chinese multicenter observational study by Yejing Zhu, Enxin Wang, Shoujie Zhao, Dandan Han, Yan Zhao, Hui Chen, Jun Zhu, Tenghui Han, Yang Bai, Yanju Lou, Yongchao Zhang, Man Yang, Luo Zuo, Jiahao Fan, Xing Chen, Jia Jia, Wenbin Wu, Weirong Ren, Tingting Bai, Shouzheng Ma, Fenghua Xu, Yuxin Tang, Ying Han, Junlong Zhao, Xingshun Qi, Jing Li, Jing Li, Xilin Du, Dongfeng Chen, Lei Liu
Published 2023-01-01
Article